Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. NRXS
NRXS logo

NRXS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NRXS News

Meta Platforms Sees 3.6% Stock Growth Driven by User Engagement

Jan 06 2026NASDAQ.COM

NeurAxis Secures Major Medical Policy Coverage for PENFS, Impacting 45 Million Members

Dec 19 2025Newsfilter

NeurAxis Prepares for 2026 Commercial Launch Amid Ongoing Double-Digit Growth and Approaching CPT Code Milestone

Nov 11 2025SeekingAlpha

NeurAxis Inc Reports Increased Losses in Q3

Nov 11 2025NASDAQ.COM

NeurAxis Achieves Impressive Financial Performance in Q3 2025 with 22% Revenue Growth

Nov 11 2025Newsfilter

Zacks Analyst Blog Features Alphabet, IBM, Merck, SandRidge Energy, and NeurAxis

Sep 17 2025NASDAQ.COM

Key Research Findings for Alphabet, IBM, and Merck

Sep 16 2025NASDAQ.COM

NeurAxis Shares Decline After Q2 Earnings Report Despite Increase in Revenue

Aug 18 2025NASDAQ.COM

NRXS Events

01/08 08:40
NeurAxis Secures Category I CPT Code for PENFS
NeurAxis announced that the Category I CPT code for Percutaneous Electrical Nerve Field Stimulation, PENFS, is now in effect, completing a successful commercial milestone for the Company. The assignment of the Category I CPT code is one of the "most significant breakthroughs in efforts towards widespread adoption of IB-Stim," the company said. This establishes a permanent, nationally recognized coding and billing pathway for NeurAxis' PENFS therapy, reflecting broad clinical acceptance and meeting the American Medical Association's, AMA, criteria for widespread utilization, clinical efficacy, and established standards of care.

NRXS Monitor News

Neuraxis Secures Major Coverage for PENFS Technology

Dec 19 2025

NRXS Earnings Analysis

No Data

No Data

People Also Watch